[1]
Asanuma, K., Yoshikawa, T., Yoshida, K., Okamoto, T., Asanuma, Y., Hayashi, T., Akita, N., Oi, T., Nishimura, A., Hasegawa, M. and Sudo, A. 2016. Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors. Cellular and Molecular Biology. 62, 6 (May 2016), 27–32.